Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3999 | INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.21 USD | 0.00% | +5.22% | +9.01% | -11.68% | 99.55 M USD | ||
| 4004 | FBIO Fortress Biotech, Inc. - Common Stock | 2.97 USD | -0.67% | -2.94% | +2.41% | +52.31% | 98.66 M USD | ||
| 4019 | PYPD PolyPid Ltd. - Ordinary Shares | 5.22 USD | -2.06% | +2.55% | +11.54% | +50.87% | 95.02 M USD | ||
| 4021 | ICCC ImmuCell Corporation - Common Stock | 10.47 USD | +1.26% | -3.06% | +8.05% | +55.34% | 94.72 M USD | ||
| 4027 | BMEA Biomea Fusion, Inc. - Common Stock | 1.29 USD | -7.86% | -5.15% | +9.32% | -33.16% | 93.27 M USD | ||
| 4028 | CGTX Cognition Therapeutics, Inc. - Common Stock | 1.04 USD | -3.70% | -7.96% | -14.05% | +85.71% | 93.08 M USD | ||
| 4037 | ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.54 USD | -7.02% | -17.90% | -0.42% | -35.32% | 85.96 M USD | ||
| 4048 | LIXT Lixte Biotechnology Holdings, Inc. - Common Stock | 7.21 USD | 0.00% | +8.10% | +7.45% | +188.40% | 89.28 M USD | ||
| 4057 | NRXS Neuraxis, Inc. Common Stock | 7.01 USD | -1.54% | -1.96% | +0.72% | +29.10% | 86.81 M USD | ||
| 4061 | MAIA MAIA Biotechnology, Inc. Common Stock | 1.43 USD | -2.72% | +0.70% | +10.00% | -31.25% | 86.95 M USD | ||
| 4064 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.96 USD | -4.95% | -1.03% | +1.05% | -12.73% | 82.12 M USD | ||
| 4073 | TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.23 USD | -0.81% | -3.15% | -3.91% | +2.50% | 84.59 M USD | ||
| 4076 | ACET Adicet Bio, Inc. - Common Stock | 9.07 USD | +5.47% | +7.21% | +23.40% | +1177.46% | 84.79 M USD | ||
| 4077 | CRDF Cardiff Oncology, Inc. - Common Stock | 1.24 USD | -8.15% | -3.88% | -17.33% | -69.31% | 84.78 M USD | ||
| 4081 | RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.68 USD | -4.23% | -11.69% | -19.05% | +7.94% | 84.24 M USD | ||
| 4091 | RLYB Rallybio Corporation - Common Stock | 15.65 USD | -0.13% | -1.45% | -2.80% | +3030.00% | 82.92 M USD | ||
| 4092 | ACRV Acrivon Therapeutics, Inc. - Common Stock | 1.93 USD | +3.76% | +10.29% | +34.97% | +46.21% | 82.61 M USD | ||
| 4102 | CSBR Champions Oncology, Inc. - Common Stock | 5.88 USD | 0.00% | -2.81% | +3.52% | -34.38% | 81.65 M USD | ||
| 4103 | LONA LeonaBio, Inc. - Common Stock | 8.63 USD | -1.26% | -0.69% | -1.03% | +28.04% | 81.07 M USD | ||
| 4108 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.64 USD | -1.20% | -10.87% | +35.54% | -8.89% | 80.73 M USD |
Nouvelles Biotechnology Stocks
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |